UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Kanawha Capital Management LLC

Kanawha Capital Management LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,401 shares of the healthcare conglomerate’s stock after selling 69 shares during the period. Kanawha Capital Management LLC’s holdings in UnitedHealth Group were worth $709,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $30,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth about $37,000. Friedenthal Financial acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $51,000. Highline Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $55,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $57,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 0.7 %

Shares of UnitedHealth Group stock opened at $531.31 on Friday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company’s 50-day simple moving average is $524.58 and its 200-day simple moving average is $563.71. The firm has a market cap of $488.96 billion, a price-to-earnings ratio of 34.28, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business posted $5.83 earnings per share. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on UNH shares. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. TD Cowen raised their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, Oppenheimer lifted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.